Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/PA/Harrisburg
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Harrisburg, PA

Studies commonly pay $75 to $4,500 per completed study

403 clinical trials are currently recruiting participants within 30 miles of Harrisburg. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

403studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Harrisburg right now

Top 25 of 403 recruiting studies, sorted by proximity — each links to its official registry page

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
UPMC Pinnacle Harrisburg — Harrisburg, Pennsylvania (0.1 mi) · Sponsor: SWOG Cancer Research Network

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer, c-MET Phase 3 Interventional 768 participants sought
Cancer Care Associates Of York /ID# 266143 — York, Pennsylvania (23.1 mi) · Sponsor: AbbVie

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

Neuroblastoma Phase 2 Interventional 98 participants sought
Penn State Milton S. Hershey Medical Center and Children's Hospital — Hershey, Pennsylvania (12.4 mi) · Sponsor: Giselle Sholler

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Lymphoma, Large B-Cell, Diffuse Phase 2 Interventional 594 participants sought
Cancer Care Associates Of York ( Site 0174) — York, Pennsylvania (23.1 mi) · Sponsor: Merck Sharp & Dohme LLC

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Non-Small Cell Lung Cancer (NSCLC) Phase 3 Interventional 750 participants sought
WellSpan Oncology Research — York, Pennsylvania (23.1 mi) · Sponsor: Bristol-Myers Squibb

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

Locally Advanced Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 1,145 participants sought
Research Site — York, Pennsylvania (23.1 mi) · Sponsor: AstraZeneca

A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

Heart Failure Phase 2 Interventional 200 participants sought
Capital Area Research LLC — Camp Hill, Pennsylvania (3.1 mi) · Sponsor: Novo Nordisk A/S

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — Hershey, Pennsylvania (12.4 mi) · Sponsor: AstraZeneca

IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

Relapsed/Refractory Primary Central Nervous System Lymphoma Phase 3 Interventional 132 participants sought
Penn State Health Milton S Hershey Medical Center — Hershey, Pennsylvania (12.4 mi) · Sponsor: Ono Pharmaceutical Co., Ltd.

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Colitis, Ulcerative Phase 3 Interventional 882 participants sought
Susquehanna Research Group — Harrisburg, Pennsylvania (0.1 mi) · Sponsor: Janssen Research & Development, LLC

WellSpan-THRIVE Cancer QOL Study

Cancer (Active Cancer, Meaning Not Being Cancer Free), of Any Stage and Involving Any Treatment/Care Regimen; i.e. Curative, Life-extending, or Palliative, Cancer (Solid Tumors) N/A Observational 1,000 participants sought
WellSpan York Cancer Center — York, Pennsylvania (23.1 mi) · Sponsor: WellSpan Health

Repeat Biliary Point of Care Ultrasound for Detecting Early Acute Cholecystitis

Cholecystitis, Acute, Biliary Diseases N/A Interventional 90 participants sought
WellSpan Health York Hospital — York, Pennsylvania (23.1 mi) · Sponsor: WellSpan Health

A Randomized Multicenter Study for Isolated Skin Vasculitis

Primary Cutaneous Vasculitis, Cutaneous Polyarteritis Nodosa Phase 2 Interventional 90 participants sought
Penn State Hershey Medical Center — Hershey, Pennsylvania (12.4 mi) · Sponsor: University of Pennsylvania

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive N/A Interventional 739 participants sought
UPMC Pinnacle Harrisburg — Harrisburg, Pennsylvania (0.1 mi) · Sponsor: SWOG Cancer Research Network

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
Penn State Milton S Hershey Medical Center — Hershey, Pennsylvania (12.4 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study

Transitional Cell Cancer of Renal Pelvis and Ureter Phase 3 Interventional 100 participants sought
The Pennsylvania State University (Penn State) Milton S. Hershey Medical Center — Hershey, Pennsylvania (12.4 mi) · Sponsor: Steba Biotech S.A.

Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study

Heavy Menstrual Bleeding, Bleeding Disorder N/A Observational 300 participants sought
Penn State Health — Hershey, Pennsylvania (12.4 mi) · Sponsor: Oregon Health and Science University

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer Phase 3 Interventional 590 participants sought
Penn State Milton S. Hershey Medical Center — Hershey, Pennsylvania (12.4 mi) · Sponsor: Revolution Medicines, Inc.

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder N/A Observational 2,240 participants sought
Cancer Care Associates of York — York, Pennsylvania (23.1 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

NSCLC, Stage I Phase 2 Interventional 244 participants sought
Penn State Cancer Institute — Hershey, Pennsylvania (12.4 mi) · Sponsor: Greg Durm, MD

Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers

Endometrial Cancer N/A Interventional 350 participants sought
Wellspan Health — York, Pennsylvania (23.1 mi) · Sponsor: WellSpan Health

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 Phase 2 Interventional 146 participants sought
Penn State Milton S Hershey Medical Center — Hershey, Pennsylvania (12.4 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8 Phase 3 Interventional 1,209 participants sought
UPMC Pinnacle Cancer Center/Community Osteopathic Campus — Harrisburg, Pennsylvania (0.1 mi) · Sponsor: NRG Oncology

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Percutaneous Coronary Intervention, Peripheral Endovascular Intervention Phase 4 Interventional 6,000 participants sought
Capital Area Research LLC — Camp Hill, Pennsylvania (3.1 mi) · Sponsor: Duke University
Actively enrolling

Studies you may be able to join near Harrisburg

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Harrisburg

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Capital Area Research LLC

★ 5.0
875 Poplar Church Rd #330, Camp Hill, PA 17011
(717) 963-8389
"The personalized care you receive here is beyond superb! Staff is easy to talk to, knowledgeable, and always on top of things. Highly recommend!"
— Donna Preas, 5★

Penn State Health Holy Spirit Medical Center

★ 2.4
503 N 21st St, Camp Hill, PA 17011
(717) 763-2100

Hershey Center for Applied Research

★ 4.5
1214 Research Blvd, Hummelstown, PA 17036
(717) 531-8520
"I go here to be seen by my<br>Doctor to get my CPAP perception renewed.<br>The people here are very friendly and helpful.<br>I definitely recommend t…"
— Kenneth Kanode, 5★

Pennsylvania Headache Center - Camp Hill

★ 5.0
205 Grandview Ave #206, Camp Hill, PA 17011
(717) 745-6223
"The PA Headache Center and Dr Peterlin are wonderful. The medical results have been fantastic, the office is well run, and they make being a patient …"
— Kristin Behfar, 5★

Clinical Research Center-Reading

2760 Century Blvd #3, Reading, PA 19610
(610) 375-2466

Center for Vein Restoration | Dr. Tanya Flohr

★ 4.8
2025 Technology Pkwy Ste 304, Mechanicsburg, PA 17050
(443) 219-0624
"Staff is fantastic. Procedures went well. The only problem is the wait time when you get there. It was too long a wait to finally see doctor. Doc…"
— Carole Miller, 5★

Clinicaltrialmd.com

★ 5.0
2014 S Tollgate Rd Ste 207, Bel Air, MD 21015
(410) 670-3076
"Wonderful staff and easy testing. Overall, a good experience!"
— Julia, 5★

Arkview Recovery Center

★ 4.8 (142 reviews)
4950 Wilson Ln, Mechanicsburg, PA 17055
(717) 876-8222
"There's so many people that work here with good intentions but they constantly change the rules instead of talking to individual people causing probl…"
— Lucy, 1★

Penn State Health Milton S. Hershey Medical Center

★ 3.1
500 University Dr, Hershey, PA 17033
(800) 243-1455

Clinical trials in Harrisburg: what's recruiting

The Harrisburg area currently has 403 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Harrisburg, the most active research areas are:

  • Cancer & Oncology16 studies
  • Heart & Vascular2 studies
  • Immune & Skin1 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Harrisburg, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Harrisburg

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Harrisburg participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Are clinical trials in Harrisburg safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Harrisburg?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Harrisburg?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Harrisburg.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Harrisburg typically complete one or two studies per year.

Paid clinical trials near Harrisburg

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of PA

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts